menu
    • menu

    Company profile for AVM Biotechnology

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    SERVICES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AVM Biotechnology is a clinical-stage biotech company located in Seattle WA led by Dr. Theresa Deisher, a biotech veteran with a productive history including 47 patents and 4 discoveries in clinical trials. The company's lead drug AVM0703, an innovative formulation of dexamethasone, when given at suprapharmacologic doses has a novel mechanism of action to mobilize the body's own natural supercharged immune cells. AVM0703 could...
    AVM Biotechnology is a clinical-stage biotech company located in Seattle WA led by Dr. Theresa Deisher, a biotech veteran with a productive history including 47 patents and 4 discoveries in clinical trials. The company's lead drug AVM0703, an innovative formulation of dexamethasone, when given at suprapharmacologic doses has a novel mechanism of action to mobilize the body's own natural supercharged immune cells. AVM0703 could be the first choice for no-option cancer, autoimmunity, and infectious disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AVM BiotechnologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1749 Dexter Ave N, Seattle, WA 98109
    Telephone
    Telephone
    1(206)906-9922
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://avmbiotech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/avm-biotechnology/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/avmbiotech?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AVM Biotechnology Selected by the National Cancer Institute to Present
    AVM Biotechnology Selected by the National Cancer Institute to Present

    11 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230911666899/en

    BUSINESSWIRE
    11 Sep 2023
    Share Share
    AVM Biotechnology Announces that the National Cancer Institute has selected AVM Biotechnology as a Showcase Company for their 2023-2024 Small Business Innovation Research (SBIR) Investor Initiatives
    AVM Biotechnology Announces that the National Cancer Institute has selected AVM Biotechnology as a Showcase Company for their 2023-2024 Small Business Innovation Research (SBIR) Investor Initiatives

    09 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230809463056/en

    BUSINESSWIRE
    09 Aug 2023
    Share Share
    AVM Bio Announces Solid Tumor & Blood Cancer Patients Treated with AVM0703
    AVM Bio Announces Solid Tumor & Blood Cancer Patients Treated with AVM0703

    01 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230731194052/en

    BUSINESSWIRE
    01 Aug 2023
    Share Share
    AVM Biotech Awarded $2M NCI SBIR PII Grant from NIH to Advance AVM0703
    AVM Biotech Awarded $2M NCI SBIR PII Grant from NIH to Advance AVM0703

    14 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220614005414/en

    BUSINESSWIRE
    14 Jun 2022
    Share Share
    AVM Biotechnology to Present Poster Highlighting the Effects of AVM0703
    AVM Biotechnology to Present Poster Highlighting the Effects of AVM0703

    01 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220601005424/en

    BUSINESSWIRE
    01 Jun 2022
    Share Share
    AVM Bio Founder and CSO to Present Company Information and Trial Progress
    AVM Bio Founder and CSO to Present Company Information and Trial Progress

    19 Apr 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220419005486/en

    BUSINESSWIRE
    19 Apr 2022
    Share Share

    Services

    Upload your portfolio for free, ask us

    Clinical Trials

    Click here to discover the service providers for Clinical Trials

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search